Abstract
Objective -The aim of this study was to determining the survival rate of patient with metastatic bone disease in Haji Adam Malik Hospital Medan. Material and Methods-The aim of this retrospective study is to determine the survival rate of metastatic bone disease patients. Fifty-five patients who diagnosed of metastatic bone disease during January 2012 – December 2017 were entered the inclusion criteria were ask and demographic data were also recorded to evaluate further associated with primary lesion, and surviving status. Survival rate was assessed by Kapplan – Meier Curve. Results- From January 2012 to December 2017, a total 55 metastatic bone disease patients were aged 43-77 years. Breast cancer (40%) was the most common primary cancer, with the lowest survival rate in cervic (10 months). Overall, patients who treat surgically and chemotherapy have survival rate 17 months. Conclusion-This study revealed that female (33 patients) have 15 months of survival rate and mael (22 patients) have 18 months of survival rate. Breast was the most common primary location tumor (40%) and have highest survival rate (20 months). Cervix was the lowest survival rate (10 months) Overall patients who underwent surgical and chemotherapy have survival rate in 17 months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
